Skip to content
Delayed ~15 min

BIIB Biogen

Permanent stock page ↗

Health Care · S&P 500

Next earnings: not announced yet

What 39 analyst firms say about Biogen: their latest ratings, price targets and how far the stock is from them. How it works

243.93 USD−10.53 (−4.14%) today
Price as of 5 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+6.4%to the avg target 259.58 USD+15.65 USD
Buy 27 · Hold 10 · Sell 1

38 rated views · 41 analyst/firm records · 39 firms

Latest report29 Oct 2026avg report date 20 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8046
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8058

Recent analyst activity · last 90 days

Our tracked history has 38 reports on BIIB from 29 analyst firms in the last 90 days (39 firms in the past year).

Comparing each firm's latest target with its previous one: 17 raised their price target, 4 left it unchanged and 4 have their first observed target in the past year.

Ratings, latest available report against the previous one: 2 upgrades and 0 downgrades.

Latest observed target change: Guggenheim raised its target from $280.00 (set 21 Jul 2026) to $300.00 on 2 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJasper HellwegBuy29 Oct 2026280.00 USD
BairdBrian SkorneyBuy29 Oct 2026290.00 USD
Bank of America SecuritiesJason ZemanskyHold22 Oct 2026244.00 USD
BarclaysEmily FieldHold28 Oct 2026230.00 USD
BernsteinJeffrey WalchBuy29 Oct 2026278.00 USD
BMO Capital MarketsEvan SeigermanHold12 Oct 2026220.00 USD
BTIGThomas ShraderHold2 Apr 2026—
Canaccord GenuitySumant KulkarniBuy29 Oct 2026272.00 USD
Cantor FitzgeraldEric SchmidtBuy29 Oct 2026270.00 USD
CitigroupGeoff MeachamHold28 Oct 2026Conflicting reports · excluded
DZ BankElmar KrausHold29 Oct 2026252.00 USD
Evercore ISIUmer RaffatBuy15 May 2026—
Freedom CapitalUnnamed analystBuy1 May 2026—
Freedom Capital MarketsIlya ZubkovBuy3 Aug 2026Conflicting reports · excluded
Goldman SachsSalveen RichterBuy30 Jul 2026290.00 USD
GuggenheimYatin SunejaBuy21 Jul 2026280.00 USD
H.C. WainwrightAndrew FeinBuy30 Jul 2026251.00 USD
HSBCMorten HerholdtSell10 Sep 2026175.00 USD
JefferiesAndrew TsaiBuy9 Oct 2026Conflicting reports · excluded
JPMorganChris SchottBuy12 Oct 2026300.00 USD
Leerink PartnersMarc GoodmanBuy17 Sep 2026260.00 USD
MizuhoSalim SyedBuy4 Aug 2026241.00 USD
Morgan StanleyMatthew HarrisonHold29 Oct 2026238.00 USD
NeedhamAmi FadiaBuy29 Oct 2026290.00 USD
OppenheimerJay OlsonBuy29 Jul 2026300.00 USD
Piper SandlerDavid AmsellemBuy25 Oct 2026245.00 USD
RBC Capital MarketsBrian AbrahamsBuy29 Oct 2026272.00 USD
RedburnSteven K ChesneyHold22 Jul 2026210.00 USD
StifelPaul Matteis—10 Sep 2026242.00 USD
TD CowenPhil NadeauBuy29 Oct 2026260.00 USD
TruistDanielle BrillBuy29 Oct 2026260.00 USD
TruistSrikripa DevarakondaBuy13 Jul 2026235.00 USD
Tudor Pickering HoltWilliam Pickering—9 Feb 2026201.00 USD
UBSAshwani VermaBuy29 Oct 2026300.00 USD
UBSMichael YeeBuy29 Oct 2026300.00 USD
WedbushLaura ChicoHold29 Oct 2026225.00 USD
Weiss RatingsUnnamed analyst—29 Oct 2026—
Wells FargoMohit BansalBuy29 Oct 2026310.00 USD
William BlairMyles R MinterBuy13 Oct 2026—
Wolfe ResearchAlexandria HammondBuy13 Aug 2026300.00 USD
Data feed RESEARCHResearch TeamHold28 Jul 2026245.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 02:20 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.